Alterations of the HBP1 transcriptional repressor are associated with invasive breast cancer

Cancer Research

Volumn 67, Issue 13, 2007, Pages 6136-6145

  Paulson, K Eric ^a,b,f   Rieger Christ, Kimberly ^e   McDevitt, Michael A ^g   Kuperwasser, Charlotte ^a,b,d   Kim, Jiyoung ^a,c   Unanue, Vincent E ^a   Zhang, Xiaowei ^a   Hu, Maowen ⁱ   Ruthazer, Robin ^b   Berasi, Stephen P ^a,j   Huang, Chun Yin ^b,d   Giri, Dilip ^b,d   Kaufman, Seth ^b,d   Dugan, John M ^f   Blum, Joanne ^h   Netto, Georges ^h   Wazer, David E ^b,d   Summerhayes, Ian C ^e   Yee, Amy S ^a,b,d  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY   (United States)

^d RHODE ISLAND HOSPITAL   (United States)

^e Cell and Molecular Biology Laboratory   (United States)

^f LAHEY HOSPITAL AND MEDICAL CENTER   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

ⁱ NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^j PFIZER INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HBP1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER INVASION; CANCER RECURRENCE; CANCER RELAPSE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DATA BASE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; RNA INTERFERENCE; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS; TRANSCRIPTION REGULATION;

ANIMALS; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH MOBILITY GROUP PROTEINS; HUMANS; MICE; MICE, SCID; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NIH 3T3 CELLS; REPRESSOR PROTEINS; TRANSCRIPTION, GENETIC; TREATMENT OUTCOME;

EID: 34447135515     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-07-0567     Document Type: Article

References (44)

1. Harris J, Lippman ME, Morrow M, Osbourne CK. Diseases of the breast. 2nd ed. Lippincott Williams & Wilkins; 2000.
2. Lavender P, Vandel L, Bannister AJ, Kouzarides T. The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A. Oncogene 1997;14:2721-8.
3. Lemercier C, Duncliffe K, Boibessot I, et al. Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression. Mol Cell Biol 2000;20:6627-37.
4. Shih HH, Xiu M, Berasi SP, et al. HMG box transcriptional repressor HBP1 maintains a proliferation barrier in differentiated liver tissue. Mol Cell Biol 2001;21:5723-32.
5. Zhuma T, Tyrrell R, Sekkali B, et al. Human HMG box transcription factor HBP1: a role in hCD2 LCR function. EMBO J 1999;18:6396-406.
6. Shih H, Tevosian SG, Yee AS. Regulation of differentiation by HBP1, a target of the retinoblastoma protein. Mol Cell Biol 1998;18:4732-43.
7. Tevosian SG, Shih H, Mendelson KG, Sheppard KA, Paulson KE, Yee AS. HBP1: a HMG box transcriptional repressor that is targeted by the retinoblastoma family. Genes Dev 1997;11:383-96.
8. Yee AS, Shih HS, Tevosian SG. New perspectives on retinoblastoma family functions in differentiation. Front Biosci 1998;3:d532-47.
9. Yee AS, Tevosian SG, Shih H. Perspectives on retinoblastoma family functions in differentiation. Pediatr Pathol Mol Med 1999;18:275-02.
10. Swanson KA, Knoepfler PS, Huang K, et al. HBP1 and Mad1 repressors bind the Sin3 corepressor PAH2 domain with opposite helical orientations. Nat Struct Mol Biol 2004;11:738-46.
11. de Chiara C, Giannini C, Adinolfi S, et al. The AXH module: an independently folded domain common to ataxin-1 and HBP1. FEBS Lett 2003;551:107-12.
12. Li Y, Welm B, Podsypanina K, et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci U S A 2003;100:15853-8.
13. Liu BY, McDermott SP, Khwaja SS, Alexander CM. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci U S A 2004;101:4158-63.
14. Reya T, Clevers H. Wnt signalling in stem cells and cancer. Nature 2005;434:843-50.
15. Sampson EM, Haque ZK, Ku MC, et al. Negative regulation of the Wnt-β-catenin pathway by the transcriptional repressor HBP1. EMBO J 2001;20:4500-11.
16. Zhang X, Kim J, Ruthazer R, et al. The HBP1 transcriptional repressor participates in RAS-induced premature senescence. Mol Cell Biol 2006;26:8252-66.
17. Wicha MS, Liu S, Dontu G. Cancer stem cells: an old idea - a paradigm shift. Cancer Res 2006;66:1883-90; discussion 95-6.
18. Polyak K, Hahn WC. Roots and stems: stem cells in cancer. Nat Med 2006;12:296-300.
19. Lin SY, Xia W, Wang JC, et al. β-Catenin, a novel prognostic marker for breast cancer: its roles in cyclin D1 expression and cancer progression. Proc Natl Acad Sci U S A 2000;97:4262-6.
20. Howe LR, Brown AM. Wnt signaling and breast cancer. Cancer Biol Ther 2004;3:36-41.
21. Lo PK, Mehrotra J, D'Costa A, et al. Epigenetic suppression of secreted frizzled related protein 1 (SFRP1) expression in human breast cancer. Cancer Biol Ther 2006;5:281-6.
22. Shulewitz M, Soloviev I, Wu T, Koeppen H, Polakis P, Sakanaka C. Repressor roles for TCF-4 and Sfrp1 in Wnt signaling in breast cancer. Oncogene 2006;25:4361-9.
23. Veeck J, Niederacher D, An H, et al. Aberrant methylation of the Wnt antagonist SFRP1 in breast cancer is associated with unfavourable prognosis. Oncogene 2006;25:3479-88.
24. Ayyanan A, Civenni G, Ciarloni L, et al. Increased Wnt signaling triggers oncogenic conversion of human breast epithelial cells by a Notch-dependent mechanism. Proc Natl Acad Sci U S A 2006;103:3799-804.
25. Goldrick MM. RNase cleavage-based methods for mutation/SNP detection, past and present. Hum Mutat 2001;18:190-204.
26. Berasi SP, Xiu M, Yee AS, Paulson KE. HBP1 repression of the p47phox gene: cell cycle regulation via the NADPH oxidase. Mol Cell Biol 2004;24:3011-24.
27. Yee AS, Paulson EK, McDevitt MA, et al. The HBP1 transcriptional repressor and the p38 MAP kinase: unlikely partners in G1 regulation and tumor suppression. Gene 2004;336:1-13.
28. Xiu M, Kim J, Sampson E, et al. The transcriptional repressor HBP1 is a target of the p38 mitogen-activated protein kinase pathway in cell cycle regulation. Mol Cell Biol 2003;23:8890-901.
29. Kim J, Zhang X, Rieger-Christ KM, et al. Suppression of Wnt signaling by the green tea compound (-)-epigallocatechin 3-gallate (EGCG) in invasive breast cancer cells. Requirement of the transcriptional repressor HBP1. J Biol Chem 2006;281:10865-75.
30. Price JE, Zhang RD. Studies of human breast cancer metastasis using nude mice. Cancer Metastasis Rev 1990;8:285-97.
31. Bafico A, Liu G, Goldin L, Harris V, Aaronson SA. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell 2004;6:497-506.
32. Lim SC. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma. Oncol Rep 2003;10:1241-9.
33. Liu CH, Chang SH, Narko K, et al. Overexpression of cyclooxygenase-2 is sufficient to induce tumorigenesis in transgenic mice. J Biol Chem 2001;276:18563-9.
34. Howe LR, Crawford HC, Subbaramaiah K, Hassell JA, Dannenberg AJ, Brown AM. PEA3is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. J Biol Chem 2001;276:20108-15.
35. Crawford YG, Gauthier ML, Joubel A, et al. Histologically normal human mammary epithelia with silenced p16(INK4a) overexpress COX-2, promoting a premalignant program. Cancer Cell 2004;5:263-73.
36. Joyce JA, Baruch A, Chehade K, et al. Cathepsin cysteine proteases are effectors of invasive growth and angiogenesis during multistage tumorigenesis. Cancer Cell 2004;5:443-53.
37. Rhodes DR, Yu J, Shanker K, et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004;6:1-6.
38. Wang Y, Klijn JG, Zhang Y, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005;365:671-9.
39. Claes K, Poppe B, Machackova E, et al. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2. Genes Chromosomes Cancer 2003;37:314-20.
40. Ishkanian AS, Malloff CA, Watson SK, et al. A tiling resolution DNA microarray with complete coverage of the human genome. Nat Genet 2004;36:299-303.
41. Polakis P. Wnt signaling and cancer. Genes Dev 2000;14:1837-51.
42. Suzuki H, Watkins DN, Jair KW, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004;36:417-22.
43. Arun B, Goss P. The role of COX-2 inhibition in breast cancer treatment and prevention. Semin Oncol 2004;31:22-9.
44. Moody SE, Perez D, Pan TC, et al. The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell 2005;8:197-209.